U.S. Food and Drug Administration Office of Pediatric Therapeutics
E886017
The U.S. Food and Drug Administration Office of Pediatric Therapeutics is an FDA office dedicated to ensuring that medical products are appropriately studied, labeled, and regulated for safe and effective use in children.
All labels observed (1)
| Label | Occurrences |
|---|---|
| U.S. Food and Drug Administration Office of Pediatric Therapeutics canonical | 1 |
How this entity was disambiguated
This entity first appeared as the object of triple T10790400 — resolving that mention is where its identity was fixed. The disambiguator weighed these candidate entities and picked the highlighted one (or “None”, minting a new entity). This is how homonymy is resolved: the same surface form can point to different entities.
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: U.S. Food and Drug Administration Office of Pediatric Therapeutics Context triple: [White Oak, Maryland, isNearFederalFacility, U.S. Food and Drug Administration Office of Pediatric Therapeutics]
-
A.
American Society for Clinical Pharmacology and Therapeutics
The American Society for Clinical Pharmacology and Therapeutics is a professional organization dedicated to advancing the science and practice of clinical pharmacology and translational medicine to improve patient care.
-
B.
Office of Orphan Products Development
The Office of Orphan Products Development is a U.S. Food and Drug Administration office that promotes the development of drugs and other medical products for rare diseases and conditions.
-
C.
Center for Drug Evaluation and Research
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
-
D.
Office of Pharmacy Affairs
The Office of Pharmacy Affairs is a division within the U.S. Health Resources and Services Administration that oversees federal drug discount initiatives for safety-net healthcare providers.
-
E.
Office of Pharmaceutical Quality
The Office of Pharmaceutical Quality is a U.S. Food and Drug Administration office responsible for ensuring the quality, safety, and consistency of human drugs throughout their lifecycle.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: U.S. Food and Drug Administration Office of Pediatric Therapeutics Target entity description: The U.S. Food and Drug Administration Office of Pediatric Therapeutics is an FDA office dedicated to ensuring that medical products are appropriately studied, labeled, and regulated for safe and effective use in children.
-
A.
American Society for Clinical Pharmacology and Therapeutics
The American Society for Clinical Pharmacology and Therapeutics is a professional organization dedicated to advancing the science and practice of clinical pharmacology and translational medicine to improve patient care.
-
B.
Office of Orphan Products Development
The Office of Orphan Products Development is a U.S. Food and Drug Administration office that promotes the development of drugs and other medical products for rare diseases and conditions.
-
C.
Center for Drug Evaluation and Research
The Center for Drug Evaluation and Research is the U.S. FDA division responsible for overseeing the safety, effectiveness, and quality of prescription and over-the-counter drugs.
-
D.
Office of Pharmacy Affairs
The Office of Pharmacy Affairs is a division within the U.S. Health Resources and Services Administration that oversees federal drug discount initiatives for safety-net healthcare providers.
-
E.
Office of Pharmaceutical Quality
The Office of Pharmaceutical Quality is a U.S. Food and Drug Administration office responsible for ensuring the quality, safety, and consistency of human drugs throughout their lifecycle.
- F. None of above. chosen
Statements (49)
| Predicate | Object |
|---|---|
| instanceOf |
FDA office
ⓘ
government organization ⓘ pediatric regulatory office ⓘ |
| collaboratesWith |
FDA Center for Biologics Evaluation and Research
NERFINISHED
ⓘ
FDA Center for Devices and Radiological Health NERFINISHED ⓘ FDA Center for Drug Evaluation and Research NERFINISHED ⓘ other federal pediatric research programs ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| field |
biologics regulation
ⓘ
drug regulation ⓘ medical device regulation ⓘ pediatric clinical research ⓘ pediatric safety ⓘ pediatrics ⓘ pharmacology ⓘ regulatory science ⓘ |
| focusesOn |
children
ⓘ
children and adolescents ⓘ infants ⓘ neonates ⓘ |
| hasMission |
coordinate pediatric activities across FDA centers
ⓘ
ensure that medical products used in children are safe and effective ⓘ improve labeling of medical products for pediatric use ⓘ promote appropriate study of medical products in pediatric populations ⓘ |
| jurisdiction |
United States government
ⓘ
surface form:
United States federal government
|
| locatedIn |
Maryland
ⓘ
Silver Spring, Maryland NERFINISHED ⓘ United States of America ⓘ
surface form:
United States
|
| parentOrganization | U.S. Food and Drug Administration NERFINISHED ⓘ |
| partOf | U.S. Food and Drug Administration NERFINISHED ⓘ |
| regulates |
pediatric use of biological products
ⓘ
pediatric use of human drugs ⓘ pediatric use of medical devices ⓘ |
| regulatoryScope |
biologic therapies for pediatric use
ⓘ
medical devices intended for children ⓘ over-the-counter drugs for pediatric use ⓘ prescription drugs for pediatric use ⓘ |
| responsibleFor |
advising on pediatric clinical trial design
ⓘ
coordinating pediatric advisory committee activities ⓘ implementing pediatric provisions of FDA legislation ⓘ reviewing pediatric safety information for medical products ⓘ |
| topic |
long-term safety of drugs in children
ⓘ
pediatric clinical trial ethics ⓘ pediatric dosing and pharmacokinetics ⓘ pediatric extrapolation of efficacy data ⓘ pediatric rare diseases ⓘ |
| worksOn |
pediatric labeling changes
ⓘ
pediatric research ethics issues ⓘ pediatric safety monitoring ⓘ |
How these facts were elicited
The pipeline generated the facts above by prompting gpt-5.1 with this entity's name + description and the instruction below.
Instruction
You are a knowledge base construction expert. Given a subject entity and a description of it, return factual statements that you know for the subject as a JSON list of dictionaries(triples), where keys must be "subject", "predicate" and "object". The number of facts may be very high, between 25 to 50 or more, for very popular subjects. For less popular subjects, the number of facts can be very low, like 5 or 10. # Requirements - If you don't know the subject at all, return an empty list. - If the subject is not a named entity, return an empty list. - Include at least one triple where predicate is "instanceOf". - Do not get too wordy. - Separate several objects into multiple triples with one object.
Input
Subject: U.S. Food and Drug Administration Office of Pediatric Therapeutics Description of subject: The U.S. Food and Drug Administration Office of Pediatric Therapeutics is an FDA office dedicated to ensuring that medical products are appropriately studied, labeled, and regulated for safe and effective use in children.
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.
White Oak, Maryland
→
isNearFederalFacility
→
U.S. Food and Drug Administration Office of Pediatric Therapeutics
ⓘ